Purchase Order 75N91024P00333
Award Date 3/19/24
Potential Completion Date 7/1/24
Potential Value $13K
Federal Agency
Ultimate Awardee
NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Becton, Dickinson and Company (BD) has been awarded a firm fixed price purchase order by the National Institutes of Health National Cancer Institute for $10,864.80. The contract calls for servicing an instrument used by approximately 75 personnel at the agency to conduct experiments involving costly reagents, animals, and extensive labor hours. Performance will take place in Bethesda, Maryland through April 2024. No set-aside designation was applied. This award is likely associated with...
- This federal contract award to Becton, Dickinson And Company (BD) is for the purchase of a 5-laser SORP cell sorter instrument to prevent disruption of ongoing research experiments at the National Cancer Institute (NCI). The $11,745.33 firm fixed-price purchase order was awarded on April 3, 2024, with an ultimate completion date of July 1, 2024. The contract does not have a set-aside designation. BD, a global medical technology company, has extensive experience providing specialized equipment...
- This is a firm fixed-price purchase order contract awarded by the National Cancer Institute, a civilian agency within the U.S. Department of Health and Human Services, to Becton, Dickinson and Company (BD) for $107,265.00. The contract does not have a set-aside designation. BD is a global medical technology company that provides a range of goods and services to U.S. government agencies, including specialized biomedical equipment, reagents, and laboratory supplies to support research and clinical...
- This firm-fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for $24,138.00. The contract is for the delivery of unspecified products or services related to BD's Biosciences division, which provides instruments, reagents, and services that support biomedical research and clinical applications through flow cytometry, cell imaging, and genomics...
- This is a delivery order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) to Becton, Dickinson and Company (BD) for $14,684.88. The contract is for the delivery of medical equipment, instruments, and supplies from BD's Biosciences division, which specializes in flow cytometry, cell imaging, and genomics technologies. The contract is a firm fixed price, with a completion date of July 12, 2011. There was no set-aside designation used for...
- This is a $71,725 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Becton, Dickinson and Company (BD) for a specialized laser option for a flow cytometry instrument. The award has no set-aside designation. BD is a global medical technology company that provides a wide range of instruments, reagents, and services to support biomedical research and clinical applications, including extensive contracts with federal healthcare agencies...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm-fixed-price delivery order to Becton, Dickinson and Company, a leading global medical technology company, to provide reagents, rental equipment, product supply, and maintenance for equipment in the laboratory of pathology. The contract has a potential value of $149,988.00 and a completion date of August 23, 2019. Becton, Dickinson and Company, operating through its IDS division as...
- This is a firm-fixed price delivery order awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for $5,509.79. The delivery order is for flow cytometric analysis of benign and malignant tumors. BD is a global medical technology company that provides a wide range of products and services to government agencies, including instrumentation, reagents, and services for biomedical research and clinical applications....
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for $33,675.60. The contract is for BD Biosciences, a division of BD, to provide biomedical instruments, reagents, and services that support flow cytometry, cell imaging, and genomics technologies. BD has extensive experience providing specialized equipment and consumables to support...
- This is a $105,926.44 firm fixed-price delivery order awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health, to Becton, Dickinson and Company (BD) under the FSS-66 Scientific Equipment and Services federal supply schedule. The contract is for a SERVICE AGREEMENT with a period of performance through February 28, 2025. This delivery order is not a set-aside contract. BD is a global medical technology company that provides specialized equipment,...